Almirall SA 2021 AR2
The report highlights Almirall's financial and ESG performance for the fiscal year 2021, emphasizing its strategic focus on Medical Dermatology. Financially, the company achieved total revenues of €836.5 million and successfully integrated into the IBEX 35 index. On the ESG front, Almirall updated its ESG Strategy for 2021-2023, achieving a 39% reduction in greenhouse gas emissions compared to 2014 and earning a B rating from the CDP. Additionally, the company launched its whistleblowing channel 'Speak Up!' and advanced its diversity initiatives, maintaining a workforce with 53% women.
Company: Almirall SA
Sector: Health Care
Country: Spain
Year: 2021
Type: AR2
Pages: 116
Almirall SA
Annual Report
The report highlights Almirall's financial and ESG performance for the fiscal year 2021, emphasizing its strategic focus on Medical Dermatology. Financially, the company achieved total revenues of €836.5 million and successfully integrated into the IBEX 35 index. On the ESG front, Almirall updated its ESG Strategy for 2021-2023, achieving a 39% reduction in greenhouse gas emissions compared to 2014 and earning a B rating from the CDP. Additionally, the company launched its whistleblowing channel 'Speak Up!' and advanced its diversity initiatives, maintaining a workforce with 53% women.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Total Waste
Women on Board
Employees